- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04421794
Effects of Foot Medial Arch Electrical Stimulation on Foot Functions and Balance
Effects of One Electrical Strengthening Session on Foot Functions and Dynamic Postural Balance: a Randomised Controlled Trial in Single Blind
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Meyrin, Switzerland, 1217
- La Tour Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Foot Posture Index (FPI) between +6 à +12 (slight pronation / increased pronation)
Exclusion Criteria:
- History of ankle or foot sprain or pain within the last 3 months
- Fracture in the leg or in the foot that occurred during the last year
- Severe foot deformity
- Self-reported disability due to neuromuscular impairment in the lower extremity
- Neurological or vestibular impairment that affected balance (diabetes mellitus, lumbosacral radiculopathy, a soft tissue disorder such as Marfan or Ehlers-Danlos syndrome)
- Any absolute contraindication to NMES (pacemaker, seizure disorders, pregnancy)
- Experience of NMES at the foot region or foot core strengthening
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: NMES group
For the NMES group one portable stimulator (Compex 2, Medicompex SA, Ecublens, Switzerland) will deliver NEMS (15 min; 75 EMS contractions completed during the training session; rise time = 0.25 s and descending time = 0.75 s).
In order to maximize muscle tension without accompanying detrimental effects on fatigue onset, biphasic symmetric regular-wave pulsed currents (85 Hz) lasting 400 μs will be delivered.
Each 4-s steady tetanic stimulation will be followed by pause lasting 8-s, during which subjects will be submaximally stimulated at 4 Hz on the medial arch muscles.
According to the recommendations, the two electrodes are placed behind the head of the first metatarsal to stimulate the medial arch intrinsic muscles.
The goal is to attain the highest tolerable level of muscle contraction without discomfort during the 15 minutes and to provide a full tetanic contraction of the intrinsic foot muscles during the contraction time.
|
Neuromuscular Electrical Stimulation (NMES) is a non pharmacological intervention that sends electrical impulses to nerves leading to muscle contraction.
The electrical stimulation can increase strength and is often used to re-educate or re-train muscles.
|
PLACEBO_COMPARATOR: Control group
For the control group the one portable stimulator (Compex 2, Medicompex SA, Ecublens, Switzerland) will be used to apply a stimulation of 15 minutes considered by TENS at the lowest intensity detectable by the participant in order to not influence the outcomes of interest.
Our aim is to strengthen IFM which is not the role of TENS.
The two electrodes will be placed on the dominant foot, at the same place than those for the NMES group.
|
Transcutaneous electrical nerve stimulation (TENS) is a nonpharmacological intervention that activates a complex neuronal network to reduce pain by activating descending inhibitory systems in the central nervous system to reduce hyperalgesia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Foot strength
Time Frame: Before and immediately after intervention
|
The change of foot strength that will be measured on a pressure platform on the dominant foot before and after intervention (NMES or TENS).
This primary outcome will be also measured on the non-dominant foot to assess cross effects.
|
Before and immediately after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dynamic postural balance
Time Frame: Before and immediately after intervention
|
The secondary outcomes include the change of dynamic postural balance in the posterior direction on the dominant foot.
All measurements will be performed on the non-dominant foot to assess cross effects.
To assess dynamic postural balance performance, we will use the Star Excursion Balance Test (SEBT).
The star excursion balance test (SEBT) is a measure of dynamic balance with good to excellent test-retest reliability.
The test will be conducted in the anterior, posterior-lateral and posterior-medial directions.
The SEBT will be performed with the subject standing barefoot so that the distal end of the longest toe of the stance foot will be placed at the center of the grid.
They will have to maintain a single-leg stance while reaching with the contralateral leg to touch as far as possible along the direction by a light touch.
The reached distances will be normalized to the respective stance-limb length (anterior superior iliac spine to the inferior border of the medial malleolus).
|
Before and immediately after intervention
|
Arch stability
Time Frame: Before and immediately after intervention
|
The secondary outcomes include the change of arch stability on the dominant foot.
This measurement will be performed on the non-dominant foot to assess cross effects.
The sit-to-stand double-leg navicular drop test will be used to evaluate longitudinal arch stability.
Participants will sit on a chair with their hips, knees, and ankles bent to 90° and the feet resting on the floor.
The inferior border of the prominent tuberosity of the navicular bone will be palpated and marked with a pen.
Next, the distance of the marked navicular point to the ground in a seated position will be measured using a steel ruler (resolution: 0.5 mm).
Then, we will ask the subject to stand barefoot on a 4-in (10.16-cm) box, placing all weight on the foot being measured, while the other foot rested lightly on the box.
Finally, the difference between the two measures (sitting - standing) will be calculated and defined as navicular drop (ND).
|
Before and immediately after intervention
|
Static plantar pressure distribution
Time Frame: Before and immediately after intervention
|
The secondary outcomes include the change of arch stability on the dominant foot. In this study the evaluation of the longitudinal arch of the foot will be made with the use of the Zebris FDM-S dynamometric platform. It will describe foot arch assessment based on the AI calculated on the basis of discretized measurements of distribution of forces on the ground, by means of the platform. According to this theory, a static arch pressure index (SAPI) will be measured by utilizing the average/maximal foot pressure distribution during static single leg standing of 30 seconds with their arms along the body while the subject will have one foot on a Zebris platform. Based on distribution of pressure on the entire foot the SAPI will be calculate as the ratio of the midfoot pressure distribution relative to the whole foot pressure distribution excluding the toes. |
Before and immediately after intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Boris Gojanovic, MD, La Tour Hospital
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2020 - 00533
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
-
King's College LondonUniversity of ReadingCompletedHealthy | Healthy AgingUnited Kingdom
Clinical Trials on NMES
-
Hospital de Clinicas de Porto AlegreCompletedType2 Diabetes MellitusBrazil
-
The Hong Kong Polytechnic UniversityUnknown
-
University of MichiganSpring Arbor UniversityCompleted
-
University Hospital, GenevaEcole Polytechnique Fédérale de Lausanne; Clinique Romande de ReadaptationActive, not recruiting
-
Barts & The London NHS TrustCompletedFractures, Closed
-
Gulhane School of MedicineRecruiting
-
Bursa Yüksek İhtisas Education and Research HospitalNot yet recruitingHemiplegia | Upper Extremity Dysfunction
-
Universidad Europea de MadridCompletedCystic Fibrosis in ChildrenSpain
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); Western UniversityRecruitingDistal Radius FractureCanada
-
Mahidol UniversityNational Taiwan UniversityCompleted